These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 16566900

  • 21. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A, Knyazhansky L, Loewenthal U, Arbelle J, Cohen H, Benjamin J.
    Depress Anxiety; 2005; 21(3):143-8. PubMed ID: 16001448
    [Abstract] [Full Text] [Related]

  • 22. Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS, Richards A, Madden E, Rao MN, O'Donovan A, Talbot LS, Rucker E, Metzler TJ, Hauger RL, Neylan TC.
    Psychopharmacology (Berl); 2014 Sep; 231(17):3581-95. PubMed ID: 24952092
    [Abstract] [Full Text] [Related]

  • 23. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA, Akil H, Haskett RF, Watson SJ.
    Biol Psychiatry; 1995 Mar 15; 37(6):355-63. PubMed ID: 7772643
    [Abstract] [Full Text] [Related]

  • 24. Twenty-four hour plasma cortisol and adrenocorticotropic hormone in Gulf War veterans: relationships to posttraumatic stress disorder and health symptoms.
    Golier JA, Schmeidler J, Legge J, Yehuda R.
    Biol Psychiatry; 2007 Nov 15; 62(10):1175-8. PubMed ID: 17612507
    [Abstract] [Full Text] [Related]

  • 25. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder.
    de Kloet CS, Vermetten E, Heijnen CJ, Geuze E, Lentjes EG, Westenberg HG.
    Psychoneuroendocrinology; 2007 Apr 15; 32(3):215-26. PubMed ID: 17296270
    [Abstract] [Full Text] [Related]

  • 26. HPA- and HPT-axis alterations in chronic posttraumatic stress disorder.
    Olff M, Güzelcan Y, de Vries GJ, Assies J, Gersons BP.
    Psychoneuroendocrinology; 2006 Nov 15; 31(10):1220-30. PubMed ID: 17081699
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
    Ryan MC, Sharifi N, Condren R, Thakore JH.
    Psychoneuroendocrinology; 2004 Sep 15; 29(8):1065-70. PubMed ID: 15219658
    [Abstract] [Full Text] [Related]

  • 31. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, Broglio F, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1999 Aug 15; 84(8):2611-5. PubMed ID: 10443648
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Adrenocorticotropic hormone/cortisol response to physical exercise in abstinent alcoholic patients.
    Coiro V, Casti A, Jotti GS, Rubino P, Manfredi G, Maffei ML, Melani A, Volta E, Chiodera P.
    Alcohol Clin Exp Res; 2007 May 15; 31(5):901-6. PubMed ID: 17386066
    [Abstract] [Full Text] [Related]

  • 34. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R, Yehuda R, Golier J, McEwen B, Harvey P, Maria NS.
    Ann N Y Acad Sci; 2006 Jul 15; 1071():410-21. PubMed ID: 16891588
    [Abstract] [Full Text] [Related]

  • 35. Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD.
    Yehuda R, Yang RK, Buchsbaum MS, Golier JA.
    Psychoneuroendocrinology; 2006 May 15; 31(4):447-51. PubMed ID: 16364555
    [Abstract] [Full Text] [Related]

  • 36. Traumatic memories, post-traumatic stress disorder and serum cortisol levels in long-term survivors of the acute respiratory distress syndrome.
    Hauer D, Weis F, Krauseneck T, Vogeser M, Schelling G, Roozendaal B.
    Brain Res; 2009 Oct 13; 1293():114-20. PubMed ID: 19376097
    [Abstract] [Full Text] [Related]

  • 37. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.
    Lembke A, Gomez R, Tenakoon L, Keller J, Cohen G, Williams GH, Kraemer FB, Schatzberg AF.
    Psychoneuroendocrinology; 2013 Jan 13; 38(1):115-21. PubMed ID: 22727477
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
    Mattsson C, Reynolds RM, Simonyte K, Olsson T, Walker BR.
    J Clin Endocrinol Metab; 2009 Apr 13; 94(4):1347-52. PubMed ID: 19141586
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.